PAR 2.56% 20.0¢ paradigm biopharmaceuticals limited..

I don’t think the price point is an issue at $1-2k for a...

  1. 87 Posts.
    lightbulb Created with Sketch. 17
    I don’t think the price point is an issue at $1-2k for a treatment course. It has a completely different IFU to Elmiron
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.